X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
original (328) 328
gastroenterology & hepatology (285) 285
humans (283) 283
male (271) 271
original article (264) 264
female (250) 250
index medicus (223) 223
middle aged (219) 219
aged (195) 195
adult (163) 163
original paper (129) 129
liver, pancreas and biliary tract (114) 114
내과학 (111) 111
surgery (103) 103
cancer (96) 96
aged, 80 and over (93) 93
retrospective studies (75) 75
mortality (70) 70
prognosis (70) 70
gastroenterology (68) 68
hepatology (62) 62
treatment outcome (62) 62
liver (60) 60
medicine & public health (60) 60
diagnosis (59) 59
management (58) 58
carcinoma (54) 54
risk factors (54) 54
digestive system diseases (51) 51
original —liver, pancreas, and biliary tract (51) 51
pancreas (51) 51
abdominal surgery (50) 50
original articles (49) 49
original article—liver, pancreas, and biliary tract (49) 49
original research (49) 49
surgical oncology (49) 49
colorectal surgery (48) 48
research (48) 48
oncology (47) 47
analysis (45) 45
pancreatic cancer (45) 45
tumors (45) 45
expression (42) 42
survival (41) 41
animals (40) 40
care and treatment (39) 39
patients (39) 39
young adult (39) 39
medicine (38) 38
chemotherapy (36) 36
adolescent (35) 35
complications (35) 35
disease (35) 35
health aspects (34) 34
pathology (34) 34
prospective studies (34) 34
immunohistochemistry (33) 33
liver cirrhosis (31) 31
studies (31) 31
pancreatitis (30) 30
therapy (30) 30
hepatocellular carcinoma (28) 28
epidemiology (27) 27
metastasis (26) 26
cirrhosis (25) 25
follow-up studies (25) 25
resection (25) 25
adenocarcinoma (24) 24
neoplasm staging (24) 24
child (23) 23
cholangiocarcinoma (23) 23
endoscopic retrograde cholangiopancreatography (23) 23
hepatocellular-carcinoma (23) 23
hospitals (23) 23
infection (23) 23
pancreatic neoplasms - pathology (23) 23
proteins (23) 23
public, environmental & occupational health (23) 23
rats (23) 23
survival analysis (23) 23
bile (22) 22
gallbladder (22) 22
pancreatic neoplasms - surgery (22) 22
risk-factors (22) 22
usage (22) 22
biopsy (21) 21
endoscopy (21) 21
liver diseases (21) 21
medical research (21) 21
sensitivity and specificity (21) 21
classification (20) 20
cohort studies (20) 20
kaplan-meier estimate (20) 20
liver cancer (20) 20
medical prognosis (20) 20
patient outcomes (20) 20
risk (20) 20
digestive system (19) 19
gemcitabine (19) 19
genetic aspects (19) 19
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastroenterology, ISSN 0944-1174, 12/2018, Volume 53, Issue 12, pp. 1261 - 1275
Nonalcoholic fatty liver disease (NAFLD) is a risk factor for type 2 diabetes. Our aim was to investigate the relationship between NAFLD and impaired glucose... 
Hyperinsulinemia | Insulin resistance | NAFLD | Postprandial hyperglycemia | IRS1 | Original —Liver, Pancreas, and Biliary Tract
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 2015, Volume 50, Issue 3, pp. 350 - 360
Journal Article
Journal of Clinical Gastroenterology, ISSN 0192-0790, 2016, Volume 50, Issue 8, pp. 670 - 675
Journal Article
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 4/2017, Volume 52, Issue 4, pp. 512 - 519
Lenvatinib is an oral inhibitor of vascular endothelial growth factor receptor 1–3, fibroblast growth factor receptor 1–4, platelet-derived growth factor... 
E7080 | Medicine & Public Health | Colorectal Surgery | Tyrosine kinase inhibitor | Hepatology | Gastroenterology | Abdominal Surgery | Hepatocellular carcinoma | Vascular endothelial growth factor inhibitor | Lenvatinib | Surgical Oncology | MODIFIED RECIST | RESPONSE EVALUATION CRITERIA | SERUM | KINASE INHIBITOR | SORAFENIB | GASTROENTEROLOGY & HEPATOLOGY | ENDOTHELIAL GROWTH-FACTOR | Body Weight | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Quinolines - administration & dosage | Carcinoma, Hepatocellular - diagnostic imaging | Young Adult | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Drug Administration Schedule | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Phenylurea Compounds - therapeutic use | Liver Neoplasms - diagnostic imaging | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Phenylurea Compounds - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Quinolines - therapeutic use | Neoplasm Staging | Quinolines - adverse effects | Tyrosine | Complications and side effects | Medical research | Care and treatment | Medicine, Experimental | Hepatoma | Growth factors | Endothelium | Index Medicus | Original —Liver, Pancreas, and Biliary Tract
Journal Article
Journal of Clinical Gastroenterology, ISSN 0192-0790, 02/2019, Volume 53, Issue 2, pp. 134 - 141
GOALS:We aimed to investigate significant factors influencing the long-term prognosis of patients who survived acute-on-chronic liver failure (ACLF).... 
decompensation | organ failure | survival | acute-on-chronic liver failure | MORTALITY | SCORE | CIRRHOTIC-PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | Liver failure | Prognosis | Research | Patient outcomes | LIVER, PANCREAS & BILIARY TRACT | Original
Journal Article
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 6/2019, Volume 54, Issue 6, pp. 541 - 548
Journal Article
Journal of Clinical Gastroenterology, ISSN 0192-0790, 07/2019, Volume 53, Issue 6, pp. 457 - 463
OBJECTIVES:Spleen stiffness (SS) correlates with liver stiffness (LS) and hepatic venous pressure gradient. The latter is currently the most accurate predictor... 
hepatic decompensation | TESTS | liver disease | CIRRHOSIS | liver stiffness | spleen stiffness | TRANSIENT ELASTOGRAPHY FIBROSCAN | GASTROENTEROLOGY & HEPATOLOGY | FAILURE | PORTAL-HYPERTENSION | ESOPHAGEAL-VARICES | DIAGNOSTIC-ACCURACY | Liver cirrhosis | Risk factors | Research | LIVER, PANCREAS & BILIARY TRACT | Original
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 12/2015, Volume 50, Issue 12, pp. 1206 - 1213
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 6/2019, Volume 54, Issue 6, pp. 558 - 570
Lenvatinib demonstrated a treatment effect on overall survival by the statistical confirmation of non-inferiority to sorafenib for the first-line treatment of... 
Medicine & Public Health | Colorectal Surgery | Hepatology | Sorafenib | Gastroenterology | Abdominal Surgery | QALY | Hepatocellular carcinoma | Lenvatinib | Surgical Oncology | Cost-effectiveness | Hepatoma | Cost benefit analysis | Comparative analysis | Medical care, Cost of | Cost analysis | Survival | Patients | Original —Liver, Pancreas, and Biliary Tract
Journal Article